Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development

by Seyhan Boyoglu-Barnum, Tatiana Chirkova, Larry J. Anderson
Published 2019-07-01

In vitro model for the assessment of human immune responses to subunit RSV vaccines.

by Tatiana Chirkova, Binh Ha, Bassam H Rimawi, Antonius G P Oomens, Tina V Hartert, Larry J Anderson
Published 2020-01-01

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization

by Sarah Wilmschen, Sabrina Schneider, Felix Peters, Lea Bayer, Leila Issmail, Zoltán Bánki, Thomas Grunwald, Dorothee von Laer, Janine Kimpel
Published 2019-07-01

Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease

by Muralidharan, Abenaya
Published 2019

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

by Christopher C. Stobart, Christina A. Rostad, Zunlong Ke, Rebecca S. Dillard, Cheri M. Hampton, Joshua D. Strauss, Hong Yi, Anne L. Hotard, Jia Meng, Raymond J. Pickles, Kaori Sakamoto, Sujin Lee, Michael G. Currier, Syed M. Moin, Barney S. Graham, Marina S. Boukhvalova, Brian E. Gilbert, Jorge C. G. Blanco, Pedro A. Piedra, Elizabeth R. Wright, Martin L. Moore
Published 2016-12-01

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types

by Lydia J. Atherton, Patricia A. Jorquera, Abhijeet A. Bakre, Ralph A. Tripp
Published 2019-10-01

RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets.

by Cory J Knudson, Stacey M Hartwig, David K Meyerholz, Steven M Varga
Published 2015-03-01

Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.

by Rachel Groppo, Joshua DiNapoli, Kwang Il Jeong, Michael Kishko, Nicholas Jackson, Harold Kleanthous, Simon Delagrave, Linong Zhang, Mark Parrington
Published 2018-01-01

Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.

by Aude Remot, Xavier Roux, Catherine Dubuquoy, Jenna Fix, Stephan Bouet, Mohammed Moudjou, Jean-François Eléouët, Sabine Riffault, Agnès Petit-Camurdan
Published 2012-01-01

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

by Angiolo Pierantoni, Maria Luisa Esposito, Virginia Ammendola, Federico Napolitano, Fabiana Grazioli, Adele Abbate, Mariarosaria del Sorbo, Loredana Siani, Anna Morena D'Alise, Alessandra Taglioni, Gemma Perretta, Antonio Siccardi, Elisa Soprana, Maddalena Panigada, Michelle Thom, Elisa Scarselli, Antonella Folgori, Stefano Colloca, Geraldine Taylor, Riccardo Cortese, Alfredo Nicosia, Stefania Capone, Alessandra Vitelli
Published 2015-01-01

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine

by Krause Anja, Xu Yaqin, Ross Sara, Wu Wendy, Joh Ju, Worgall Stefan
Published 2011-07-01

Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.

by Koen B Pouwels, Sefika E Bozdemir, Selen Yegenoglu, Solmaz Celebi, E David McIntosh, Serhat Unal, Maarten J Postma, Mustafa Hacimustafaoglu
Published 2016-01-01

Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).

by In Su Cheon, Byoung-Shik Shim, Sung-Moo Park, Youngjoo Choi, Ji Eun Jang, Dae Im Jung, Jae-Ouk Kim, Jun Chang, Cheol-Heui Yun, Man Ki Song
Published 2014-01-01

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting

by Patricia T. Campbell, Nicholas Geard, Alexandra B. Hogan
Published 2020-11-01

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.

by Elissa Malkin, Ram Yogev, Nazha Abughali, Joseph Sliman, C Kathy Wang, Fengrong Zuo, Chin-Fen Yang, Mark Eickhoff, Mark T Esser, Roderick S Tang, Filip Dubovsky
Published 2013-01-01

Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries

by Rachel Cevigney, Christopher Leary, Bernard Gonik
Published 2021-01-01

Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine

by Marsha S. Russell, Marybeth Creskey, Abenaya Muralidharan, Abenaya Muralidharan, Changgui Li, Jun Gao, Wangxue Chen, Louise Larocque, Jessie R. Lavoie, Aaron Farnsworth, Michael Rosu-Myles, Michael Rosu-Myles, Anwar M. Hashem, Carole L. Yauk, Jingxin Cao, Gary Van Domselaar, Terry Cyr, Xuguang Li, Xuguang Li
Published 2019-03-01

A Research Framework for Evaluation of RSV Vaccination Use and RSV Outcomes Among Premature Infants Under One Year of Age

by Gibson, Phylliscia
Published 2016

PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease

by Abenaya Muralidharan, Louise Larocque, Marsha Russell, Marybeth Creskey, Changgui Li, Wangxue Chen, Gary Van Domselaar, Jingxin Cao, Terry Cyr, Michael Rosu-Myles, Lisheng Wang, Xuguang Li
Published 2019-08-01

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya

by Joyce U. Nyiro, Elizabeth Bukusi, Dufton Mwaengo, David Walumbe, Amek Nyaguara, Bryan Nyawanda, Nancy Otieno, James A. Berkley, Patrick Munywoki, D. James Nokes
Published 2020-11-01